Before you acquire a cosmetic surgery center, verify these 20 critical checkpoints — from CPOM compliance and malpractice exposure to physician retention and revenue sustainability.
Acquiring a cosmetic surgery center in the $1M–$5M revenue range requires a disciplined due diligence process that goes well beyond standard business financials. These practices operate at the intersection of healthcare regulation and consumer discretionary spending, creating layered risks around corporate practice of medicine (CPOM) laws, physician key-man dependency, malpractice tail liability, and staff retention. This checklist organizes the most critical areas buyers must investigate before signing a purchase agreement, helping you avoid deal-killers and structure a transaction that protects your investment from day one.
Verify the practice operates within state healthcare laws, holds required licenses, and is structured for a compliant ownership transfer.
Review MSO/PC structure and confirm CPOM compliance in the practice's state.
State CPOM laws prohibit non-physicians from owning medical practices; an improperly structured deal can be void or illegal.
Red flag: No MSO structure exists and the seller has not consulted healthcare counsel on ownership transfer mechanics.
Confirm all physician, facility, and DEA licenses are current and transferable.
Lapsed or non-transferable licenses can shut down operations immediately post-close and require lengthy reinstatement.
Red flag: DEA registrations or facility licenses are in the selling physician's name with no clear transfer pathway.
Verify accreditation status with AAAHC or Joint Commission and review inspection history.
Accreditation is required for in-office surgical procedures; lapses expose buyers to regulatory shutdown and liability.
Red flag: Accreditation is expired, under review, or the center has had two or more deficiency findings in the past three years.
Audit all state fee-splitting and anti-kickback compliance for referral and vendor arrangements.
Illegal fee-splitting arrangements can result in license revocation and significant financial penalties post-acquisition.
Red flag: Undocumented referral payments or revenue-sharing arrangements with non-physician parties are discovered.
Assess all past, pending, and potential liability exposure to understand insurance obligations and indemnification needs.
Obtain a full 5-year malpractice claims history including settled, dismissed, and open cases.
A pattern of claims signals clinical quality issues that will affect insurability, premiums, and post-close liability exposure.
Red flag: Multiple paid malpractice claims or a currently open lawsuit involving the selling physician or clinical staff.
Confirm tail insurance coverage obligations and who bears the cost at closing.
Tail coverage for claims-made policies can cost 200–300% of annual premiums and is a significant deal cost if unaddressed.
Red flag: Seller refuses to fund tail coverage and the purchase agreement does not clearly assign this obligation.
Review state medical board complaint history and disciplinary actions for all physicians.
Board complaints or disciplinary actions can restrict physician scope of practice or trigger license suspension post-close.
Red flag: Any active board investigation or prior license suspension not disclosed during initial marketing.
Check litigation history beyond malpractice including employment claims, vendor disputes, and patient complaints.
Non-malpractice litigation can indicate operational dysfunction and create inherited liabilities.
Red flag: Active employment discrimination or wage claims involving current staff that will transfer with the business.
Validate the sustainability, source, and concentration of revenue to ensure the business performs post-close without the seller.
Analyze 3 years of procedure revenue by type — surgical vs. non-surgical — and by physician.
Revenue concentrated in one procedure type or one surgeon creates fragility that threatens post-close cash flow.
Red flag: More than 70% of revenue is attributable to surgical cases performed exclusively by the selling physician.
Review patient retention rates and repeat-visit frequency for non-surgical revenue streams.
High repeat rates for Botox, fillers, and laser treatments signal durable revenue that survives physician transitions.
Red flag: Non-surgical repeat visit rate below 40% or a declining active patient count over the prior 24 months.
Reconcile EMR procedure records against financial statements to confirm revenue accuracy.
Discrepancies between clinical records and reported revenue can indicate unreported cash income or billing fraud.
Red flag: Significant gaps between procedure volume recorded in EMR and revenue reported on tax returns or P&L statements.
Evaluate accounts receivable aging and payor mix for any third-party insurance billing exposure.
While mostly cash-pay, any insurance billing adds collection risk and compliance obligations that affect working capital.
Red flag: AR aging shows more than 20% of balances over 90 days or undisclosed insurance billing with outstanding audits.
Assess the likelihood that clinical talent — the primary revenue-generating asset — will remain post-acquisition.
Review employment agreements, non-competes, and non-solicitation clauses for all physicians and key injectors.
Without enforceable post-close agreements, key providers can leave and take patients, destroying acquired revenue.
Red flag: No non-compete exists for the selling physician, or existing agreements are unenforceable in the practice's state.
Assess whether associate physicians or nurse practitioners independently drive measurable revenue.
Practices with revenue-generating associate providers have significantly lower key-man risk and stronger post-close sustainability.
Red flag: Associates account for less than 15% of total revenue and have no independent patient relationships.
Conduct confidential retention interviews or surveys with lead aesthetic nurses and practitioners.
Skilled injectors and aestheticians often drive 30–50% of non-surgical revenue and are difficult to replace quickly.
Red flag: Two or more high-revenue aesthetic staff have indicated they will leave if the founding physician exits.
Review staff tenure, turnover history, and compensation benchmarks against market rates.
High turnover signals cultural or compensation issues that will increase post-close operating costs and training burden.
Red flag: Average clinical staff tenure under 18 months or compensation significantly below market with no retention incentives.
Evaluate the systems and channels that drive patient acquisition and operational efficiency independent of the founder.
Assess EMR system, patient database ownership, and data migration feasibility post-close.
Patient data is a core asset; restricted access or non-transferable EMR licenses can impair operations on day one.
Red flag: EMR contract is non-transferable or patient records are maintained informally outside a certified system.
Audit digital marketing performance including SEO, paid search, social media following, and review volume.
Practices with documented, system-driven patient acquisition are less dependent on the founder's personal brand.
Red flag: Substantially all new patient acquisition is attributable to personal referrals to the selling surgeon with no digital infrastructure.
Review all equipment leases, service contracts, and identify capital expenditure needs within 24 months.
Aging laser and surgical equipment can require $200K–$500K in near-term replacement, eroding projected returns.
Red flag: Core revenue-generating equipment is more than 7 years old with no service contracts or documented maintenance history.
Evaluate facility lease terms including length, renewal options, and landlord consent requirements for assignment.
A short remaining lease or landlord veto rights over assignment creates operational and financing risk at closing.
Red flag: Facility lease expires within 18 months with no renewal option or landlord has right to terminate on ownership change.
Find Cosmetic Surgery Center Businesses For Sale
Vetted targets with diligence packages — skip the cold search.
It depends on the state. Many states enforce corporate practice of medicine (CPOM) laws that prohibit non-physicians from owning a medical practice directly. The standard solution is a Management Services Organization (MSO) structure, where a non-physician-owned entity handles all business operations — billing, marketing, staffing, facilities — under a management services agreement with a physician-owned professional corporation (PC) that employs the physicians and holds the clinical licenses. Buyers should retain healthcare-specialized legal counsel to structure the deal correctly for the specific state before signing any letter of intent.
Start by pulling revenue attribution from the EMR and financial statements to determine what percentage of total collections is tied to procedures performed exclusively by the selling physician. A healthy practice for acquisition should have the selling surgeon contributing no more than 50–60% of revenue, with the remainder driven by associate physicians, nurse practitioners, or aesthetic nurses. You should also assess whether these providers have independent patient relationships, are under employment agreements with non-solicitation clauses, and have indicated willingness to stay post-close. Seller earnouts tied to revenue retention over 24–36 months are a common tool to align incentives during the physician transition period.
If the practice carries claims-made malpractice insurance — which is standard for surgical practices — the selling physician will need a tail policy (extended reporting endorsement) to cover claims arising from procedures performed before the sale date. Tail premiums typically cost 150–300% of the annual premium and can range from $30,000 to $150,000 or more depending on specialty, claims history, and coverage limits. Buyers should negotiate clearly in the purchase agreement who pays for tail coverage — it is typically the seller's obligation — and require proof of binding before closing. Failure to address this leaves the buyer exposed to inherited liability.
SBA 7(a) loans are the most common financing vehicle for individual buyers and physician entrepreneurs acquiring cosmetic surgery centers in this range, typically covering 70–80% of the purchase price with a 10-year term and rates around prime plus 2–3%. The remaining 20–30% is often structured as a seller note, which also signals seller confidence in post-close performance. For deals above $2M in EBITDA, private equity platforms or family offices may use conventional leverage with bank debt. In all cases, lenders will require 3 years of CPA-reviewed financials, proof of licensing and accreditation, and often a physician transition and employment agreement as a condition of funding.
More Cosmetic Surgery Center Guides
More Due Diligence Checklists
Stop cold-searching. Find signal-scored Cosmetic Surgery Center targets with seller motivation already identified.
Create your free accountNo credit card required
For Buyers
For Sellers